Literature DB >> 10528163

Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.

S Goenka1, J Youn, L M Dzurek, U Schindler, L Y Yu-Lee, M Boothby.   

Abstract

The cytokines IL-4 and IFN-gamma exert biologically antagonistic effects that in part reflect opposing influences on gene transcription. While the molecular mechanisms for IL-4-mediated transcription activation have been extensively studied, little is known about molecular mechanisms required for IL-4 inhibition of IFN-gamma signaling. We have investigated IL-4 inhibition of the IFN-gamma-inducible promoter for IFN regulatory factor-1 (IRF-1). In a cell line with low endogenous Stat6, increasing levels of activated Stat6 at constant doses of IFN-gamma and IL-4 leads to inhibition of the IRF-1 promoter. The Stat1-dependent IFN-gamma activation sequence element of the IRF-1 promoter is a target for Stat6-mediated inhibition despite apparently normal Stat1 DNA binding. However, our data are inconsistent with competition between Stat1 and Stat6 for access to the IRF-1 IFN-gamma activation sequence or for an essential coactivator as a mechanism for this Stat6-mediated inhibition. Instead, the data demonstrate that a threshold of Stat6 transcription activation domains is required for IL-4-dependent inhibition. The findings provide evidence of a novel mechanism in which the Stat6 transcription activation domains play a critical role in the IL-4-mediated inhibition of an IFN-gamma-inducible promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528163

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  IL-4 signaling, gene transcription regulation, and the control of effector T cells.

Authors:  M Boothby; A L Mora; M A Aronica; J Youn; J R Sheller; S Goenka; L Stephenson
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

Review 3.  Transcriptional regulation by STAT6.

Authors:  Shreevrat Goenka; Mark H Kaplan
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

4.  A New IRF-1-Driven Apoptotic Pathway Triggered by IL-4/IL-13 Kills Neonatal Th1 Cells and Weakens Protection against Viral Infection.

Authors:  Mindy M Miller; Subhasis Barik; Alexis N Cattin-Roy; Tobechukwu K Ukah; Christine M Hoeman; Habib Zaghouani
Journal:  J Immunol       Date:  2019-04-17       Impact factor: 5.422

5.  Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor.

Authors:  Shreevrat Goenka; Mark Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

6.  Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).

Authors:  Min Wei; Bingya Liu; Qinlong Gu; Liping Su; Yingyan Yu; Zhenggang Zhu
Journal:  Cell Oncol (Dordr)       Date:  2012-11-27       Impact factor: 6.730

Review 7.  Regulation of chemokine expression by antiinflammatory cytokines.

Authors:  Thomas A Hamilton; Yoshihiro Ohmori; Julie Tebo
Journal:  Immunol Res       Date:  2002       Impact factor: 4.505

8.  Anti-inflammatory cytokine interleukin-4 inhibits inducible nitric oxide synthase gene expression in the mouse macrophage cell line RAW264.7 through the repression of octamer-dependent transcription.

Authors:  Miki Hiroi; Yoshiichi Sakaeda; Hana Yamaguchi; Yoshihiro Ohmori
Journal:  Mediators Inflamm       Date:  2013-12-29       Impact factor: 4.711

9.  Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.

Authors:  Min Wei; Qi He; Zhongyin Yang; Zhiwei Wang; Qing Zhang; Bingya Liu; Qinlong Gu; Liping Su; Yingyan Yu; Zhenggang Zhu; Guofeng Zhang
Journal:  BMC Cancer       Date:  2014-01-08       Impact factor: 4.430

10.  Reprogramming of macrophages employing gene regulatory and metabolic network models.

Authors:  Franziska Hörhold; David Eisel; Marcus Oswald; Amol Kolte; Daniela Röll; Wolfram Osen; Stefan B Eichmüller; Rainer König
Journal:  PLoS Comput Biol       Date:  2020-02-25       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.